arrow
R

Ryusuke Hatae

kyushu university
H指数:22
被引数:2,240

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chromosome 14q loss is associated with adverse survival and a distinct transcriptional phenotype in IDH-wildtype glioblastoma

染色体14q缺失与IDH野生型胶质母细胞瘤的不良生存和独特的转录组表型相关

2026-11-100
OAAI
EGFR and TP53 mutations refine prognostic stratification of IDH-wildtype astrocytomas, not elsewhere classified

EGFR和TP53突变细化了IDH野生型星形细胞瘤,非其他分类的预后分层

2026-08-030
OA
Comparative evaluation of CAR-expressing T-, NK-, NKT-cells, and macrophages in an immunocompetent mouse glioma model

CAR表达T细胞、NK细胞、NKT细胞及巨噬细胞在免疫健全小鼠胶质瘤模型中的比较评估

2025-04-120
OA
Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma

p16免疫阴性和甲硫腺苷磷酸化酶保留的细胞周期蛋白依赖性激酶抑制剂2A/B的半合子缺失可预测IDH突变型成人神经胶质瘤的不良预后

2024-05-083
OAAI
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade
2024-04-013
OAAI
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer
2022-12-149
PRE
CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma
2021-06-2916
OAAI
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations

在IDH1/2突变的成人弥漫性神经胶质瘤中,无论1p/19q状态如何,TERT启动子突变均赋予良好的预后

2020-11-2332
OAAI